Method of evaluating compound efficacious in treating obesity

Details Method of evaluating compound efficacious in treating obesity Method of evaluating compound efficacious in treating obesity

2004-07-09

2009-02-17

Zara, Jane (Department: 1635)

Drug, bio-affecting and body treating compositions

In vivo diagnosis or in vivo testing

C424S009200, C435S004000, C435S006120, C435S007720, C435S375000

Reexamination Certificate

active

07491381

ABSTRACT:
Examination of obesity or emaciation is performed based on expression levels of LCE gene or protein in a test tissue or a test cell or a polymorphism of the gene. Evaluation of compounds including screening of therapeutic agents for obesity or emaciation is performed utilizing the nature of LCE gene or protein.

REFERENCES:
patent: WO 02/44320 (2002-06-01), None
patent: WO 02/099068 (2002-12-01), None
patent: WO 2004/013347 (2004-02-01), None
patent: WO 2005/030985 (2005-04-01), None
Moon, Y-A. et al., J. Biol. Chem., vol. 276, No. 48, pp. 45,358-45,366 (2001).
Matsuzaka, T., et al.,J. Lipid Res., vol. 43, pp. 911-920 (2002).
Pan, D.A. et al, J. Clin. Invest., vol. 96, pp. 2802-2808 (1995).
Suneja, S. K., et al., “Enzyme Site-Specific Changes in Hepatic Microsomal Fatty Acid Chain Elongation in Streptozotocin-Induced Diabetic Rats”, Biochimica et Biophysica Acta, vol. 1042, pp. 81-85 (1990).
Elbashir, S. M., et al., “Duplexes of 21-Nucleotide RNAs Mediate RNA Interference in Cultured Mammalian Cells”, Nature, vol. 411, pp. 494-498 (2001).
Higuchi, H., et al., “Functional Inhibition of the p75 Receptor Using a Small Interfering RNA”, Biochemical and Biophysical Research Communications, vol. 301, pp. 804-809 (2003).
Harborth, J., et al., “Identification of Essential Genes in Cultured Mammalian Cells Using Small Interfering RNAs”, Journal of Cell Science, vol. 114, pp. 4557-4565 (2001).
Inagaki et al., Biosci. Biotech. Biochem., vol. 66 (2002), pp. 613-621, “Identification and expression of a rat fatty acid elongase involved in biosynthesis . . . ”.
Memon et al., Diabetes, vol. 48 (1999), pp. 121-127, “Regulation of putative fatty acid transporters and Acyl-CoA synthetase in liver . . . ”.
Angulo, N. Eng. J. Med., vol. 346 (2002), pp. 1221-1231, “Nonalcoholic fatty liver disease”.
The Merck Manual (15th ed.), Chapters 66, 67, and 69 (1987).
The Merck Manual (15th ed.), Chapter 79 (1987).

Affiliated with

Also associated with

Rating

Method of evaluating compound efficacious in treating obesity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of evaluating compound efficacious in treating obesity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of evaluating compound efficacious in treating obesity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4067370